Literature DB >> 6281229

Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.

H C Neu, P Labthavikul.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281229     DOI: 10.1093/jac/9.suppl_a.101

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Antibacterial activity of temocillin in combination with other beta-lactam antibiotics.

Authors:  L Verbist; J Verhaegen
Journal:  Drugs       Date:  1985       Impact factor: 9.546

2.  Combinations of beta lactam antibiotics.

Authors:  S J Pedler; A J Bint
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

3.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

4.  Effect of temocillin in combination with other beta-lactam antibiotics.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

5.  In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.

Authors:  J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.

Authors:  M A Buesing; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.

Authors:  N X Chin; K Jules; H C Neu
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

8.  Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.

Authors:  M B Bansal; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.